An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancerHOTTA, Katsuyuki; UEOKA, Hiroshi; KIURA, Katsuyuki et al.Lung cancer. 2004, Vol 46, Num 1, pp 61-76, issn 0169-5002, 16 p.Article

Association of the benefit from gefitinib monotherapy with smoking status in Japanese patients with non-small-cell lung cancerHOTTA, Katsuyuki; KIURA, Katsuyuki; TAKIGAWA, Nagio et al.Lung cancer. 2008, Vol 62, Num 2, pp 236-241, issn 0169-5002, 6 p.Article

Effect of AZD1480 in an epidermal growth factor receptor-driven lung cancer modelMURAKAMI, Toshi; TAKIGAWA, Nagio; KIURA, Katsuyuki et al.Lung cancer. 2014, Vol 83, Num 1, pp 30-36, issn 0169-5002, 7 p.Article

Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experienceKATO, Yuka; HOTTA, Katsuyuki; SHINKAI, Tetsu et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 5, pp 943-950, issn 0344-5704, 8 p.Article

Impact of physical size on gefitinib efficacy in patients with non-small cell lung cancer harboring EGFR mutationsICHIHARA, Eiki; HOTTA, Katsuyuki; TANIMOTO, Mitsune et al.Lung cancer. 2013, Vol 81, Num 3, pp 435-439, issn 0169-5002, 5 p.Article

Combination of SN-38 with gefitinib or imatinib overcomes SN-38-resistant small-cell lung cancer cellsTAKIGAWA, Nagio; TAKEYAMA, Masami; FUJIWARA, Yoshiro et al.Oncology reports. 2007, Vol 17, Num 5, pp 983-987, issn 1021-335X, 5 p.Article

Impact of HER2 and EGFR gene status on gefitinib-treated patients with nonsmall-cell lung cancerSOH, Junichi; TOYOOKA, Shinichi; KIURA, Katsuyuki et al.International journal of cancer. 2007, Vol 121, Num 5, pp 1162-1167, issn 0020-7136, 6 p.Article

Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective responseFUJII, Masanori; HOTTA, Katsuyuki; TAKIGAWA, Nagio et al.Lung cancer. 2012, Vol 78, Num 1, pp 107-111, issn 0169-5002, 5 p.Article

Gefitinib induces premature senescence in non-small cell lung cancer cells with or without EGFR gene mutationHOTTA, Katsuyuki; TABATA, Masahiro; TANIMOTO, Mitsune et al.Oncology reports. 2007, Vol 17, Num 2, pp 313-317, issn 1021-335X, 5 p.Article

Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapyHOTTA, Katsuyuki; FUJIWARA, Yoshiro; MATSUO, Keitaro et al.Cancer. 2007, Vol 109, Num 5, pp 939-948, issn 0008-543X, 10 p.Article

The combination effect of amrubicin with cisplatin or irinotecan for small-cell lung cancer cellsTAKIGAWA, Nagio; TAKEYAMA, Masako; KIURA, Katsuyuki et al.Oncology reports. 2006, Vol 15, Num 4, pp 837-842, issn 1021-335X, 6 p.Article

A phase I study and pharmacokinetics of irinotecan (CPT-11) and paclitaxel in patients with advanced non-small cell lung cancerHOTTA, Katsuyuki; UEOKA, Hiroshi; TANIMOTO, Mitsune et al.Lung cancer. 2004, Vol 45, Num 1, pp 77-84, issn 0169-5002, 8 p.Article

Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinomaTOYOOKA, Shinichi; TAKANO, Toshimi; AOE, Keisuke et al.Cancer science. 2008, Vol 99, Num 2, pp 303-308, issn 1347-9032, 6 p.Article

Isolated metastasis of lung cancer to the thyroid glandOSAWA, Masahiro; TAKIGAWA, Nagio; KIURA, Katsuyuki et al.Lung cancer. 2007, Vol 58, Num 1, pp 156-158, issn 0169-5002, 3 p.Article

Clustered incidence of acute promyelocytic leukemia during gefitinib treatment for non-small-cell lung cancer : Experience at a single institutionMATSUO, Keitaro; KIURA, Katsuyuki; SHINAGAWA, Katsuji et al.American journal of hematology. 2006, Vol 81, Num 5, pp 349-354, issn 0361-8609, 6 p.Article

Identification of epigenetic aberrant promoter Methylation in serum DNA is useful for early detection of lung cancerFUJIWARA, Keiichi; FUJIMOTO, Nobukazu; TANIMOTO, Mitsune et al.Clinical cancer research. 2005, Vol 11, Num 3, pp 1219-1225, issn 1078-0432, 7 p.Article

A phase II study of S-1 chemotherapy with concurrent thoracic radiotherapy in elderly patients with locally advanced non-small-cell lung cancer: The Okayama Lung Cancer Study Group Trial 0801AOE, Keisuke; TAKIGAWA, Nagio; HOSOKAWA, Shinobu et al.European journal of cancer (1990). 2014, Vol 50, Num 16, pp 2783-2790, issn 0959-8049, 8 p.Article

A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401NOGAMI, Naoyuki; HOTTA, Katsuyuki; HARITA, Shingo et al.Lung cancer. 2011, Vol 74, Num 1, pp 80-84, issn 0169-5002, 5 p.Article

Association between poor performance status and risk for toxicity during erlotinib monotherapy in Japanese patients with non-small cell lung cancer: Okayama Lung Cancer Study Group experienceHOTTA, Katsuyuki; KIURA, Katsuyuki; TANIMOTO, Mitsune et al.Lung cancer. 2010, Vol 70, Num 3, pp 308-312, issn 0169-5002, 5 p.Article

Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: OLCSG 0007SEGAWA, Yoshihiko; KIURA, Katsuyuki; DEOKA, Hiroshi et al.Journal of clinical oncology. 2010, Vol 28, Num 20, pp 3299-3306, issn 0732-183X, 8 p.Article

A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancerCHIKAMORI, Kenichi; KISHINO, Daizo; UEOKA, Hiroshi et al.Lung cancer. 2009, Vol 65, Num 1, pp 74-79, issn 0169-5002, 6 p.Article

Epidermal growth factor receptor mutation status and adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lungSUEHISA, Hiroshi; TOYOOKA, Shinichi; DATE, Hiroshi et al.Journal of clinical oncology. 2007, Vol 25, Num 25, pp 3952-3957, issn 0732-183X, 6 p.Article

The impact of epidermal growth factor receptor gene status on gefitinib-treated japanese patients with non-small-cell lung cancerICHIHARA, Shuji; TOYOOKA, Shinichi; AOE, Motoi et al.International journal of cancer. 2007, Vol 120, Num 6, pp 1239-1247, issn 0020-7136, 9 p.Article

A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancerSHIBAYAMA, Takuo; HOTTA, Katsuyuki; KUYAMA, Shoichi et al.Lung cancer. 2006, Vol 53, Num 2, pp 189-195, issn 0169-5002, 7 p.Article

Clinical factors affecting acquired resistance to gefitinib in previously treated Japanese patients with advanced nonsmall cell lung cancerSEGAWA, Yoshihiko; HOTTA, Katsuyuki; UMEMURA, Shigeki et al.Cancer. 2006, Vol 107, Num 8, pp 1866-1872, issn 0008-543X, 7 p.Article